BioPharmSignal logoBioPharmSignal

Biotech News

iRhythm Holdings to Report Third Quarter 2026 Financial Results on November 5, 2026

iRhythm (IRTC)iRhythmEarnings

iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced that it will release financial results for the third quarter 2026 after the close of trading on Thursday, November 5, 2026. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.

Related news

IRTCiRhythm2026-08-06 20:05 EST

iRhythm Holdings Announces Second Quarter 2026 Financial Results

CVRXCVRx2026-10-22 20:30 EST

CVRx to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call on November 5, 2026

SGHTSight Sciences2026-10-21 20:05 EST

Sight Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026

OMOutset Medical2026-10-21 20:05 EST

Outset Medical to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026

RXSTRxSight2026-10-20 20:05 EST

RxSight, Inc. to Report Third Quarter 2026 Financial Results on November 3

STXSStereotaxis2026-10-20 11:40 EST

Stereotaxis to Report Third Quarter 2026 Financial Results on November 10, 2026

ADPTAdaptive Biotechnologies2026-10-14 20:05 EST

Adaptive Biotechnologies to Report Third Quarter 2026 Financial Results on November 4, 2026

PRCTPROCEPT BioRobotics2026-10-12 20:05 EST

PROCEPT BioRobotics® to Report Third Quarter 2026 Financial Results on November 4th, 2026

PLSEPulse Biosciences2026-10-22 20:05 EST

Pulse Biosciences Schedules Third Quarter 2026 Financial Results Conference Call for November 5, 2026

SENSSenseonics2026-10-21 12:00 EST

Senseonics Holdings, Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call for November 9, 2026 at 4:30 P.M. Eastern Time

View all latest news

iRhythm

Ambulatory Cardiac Monitoring iRhythm is a digital healthcare company focused on detecting and characterizing cardiac arrhythmias. It combines wearable biosensors, cloud-based analytics and proprietary algorithms to convert extended electrocardiographic recordings into clinically actionable reports. Zio Platform The Zio portfolio...

Recent company news

IRTCiRhythm2026-10-15 20:05 EST

iRhythm Holdings to Report Third Quarter 2026 Financial Results on November 5, 2026

IRTCiRhythm2026-10-05 13:05 EST

iRhythm Completes Acquisition of VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home Care

IRTCiRhythm2026-10-02 20:41 EST

iRhythm Provides Update on Cybersecurity Incident Previously Disclosed in June 2026

IRTCiRhythm2026-08-26 20:05 EST

iRhythm Holdings to Participate in Wells Fargo 21st Annual Healthcare Conference

IRTCiRhythm2026-08-06 20:06 EST

iRhythm to Acquire VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home Care

Stock data

Close
113.55 USD
Market cap
3.47B USD
Exchange
NASDAQ
Sector
MedTech
Location
United States